Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

GobyMeds vs Next Vial

GobyMeds
Graded #142

Higher grade

vs+9.600000000000009
Next Vial
Graded #345

Lower grade

The verdict

GobyMeds takes it — 68.9/100 to 59.3/100.

GobyMeds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Affordable telehealth provider offering compounded semaglutide only.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueGobyMeds +27
67
40
Dose & formulationGobyMeds +23
75
52
Clinical oversightEven
82
82
Labs & monitoringGobyMeds +1
53
52
FulfillmentNext Vial +16
70
86
Contract termsEven
55
55
GobyMeds · left barNext Vial · right bar

The numbers

MetricGobyMedsNext Vial
WeighScore68.9/10059.3/100
GradeCC
Scorecard rank#142#345
Semaglutide$169/mo (all doses, compounded)$250/mo (compounded)
Tirzepatide$299/mo (all doses, compounded)Not disclosed
CoverageCoverage not published49 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
GobyMeds

Graded #142 · C

Strengths

  • Aggressively low monthly pricing
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details
Next Vial

Graded #345 · C

Strengths

  • LegitScript verified with named pharmacy partner (Manifest Pharmacy, Greer, SC)
  • No membership fees — one all-in price covering consultation, medication, and shipping
  • Compounded semaglutide, tirzepatide, and microdose options available
  • Free rushed shipping; serves 49 states nationwide
  • Board-certified physician oversight with ongoing provider support

Where it loses points

  • Tirzepatide pricing not listed publicly (starting price covers GLP-1 generally)
  • Compounded medications are not FDA-approved
  • Labs and nutritional coaching not disclosed
  • Microdose pricing not published on product page
  • Alaska not listed among served states

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard